0O5H.IL
Get informed when a big investor buys or sells
+ FollowMarch 5, 2026 - AI Summary
Overvalued by 15.6% based on the discounted cash flow analysis.
| Market cap | $20.03 Billion |
|---|---|
| Enterprise Value | $31.51 Billion |
| Dividend Yield | $2.40 (4.41%) |
| Earnings per Share | $-1.35 |
| Beta | 1.07 |
| Outstanding Shares | 382,083,120 |
| P/E Ratio | -57.69 |
|---|---|
| PEG | -39.57 |
| Price to Sales | 1.32 |
| Price to Book Ratio | 2.99 |
| Enterprise Value to Revenue | 1.9 |
| Enterprise Value to EBIT | 45.25 |
| Enterprise Value to Net Income | -56 |
| Total Debt to Enterprise | 0.44 |
| Debt to Equity | 1.83 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Elekta AB is a medical technology company. It engages in the provision of clinical solutions for the treatment of cancers and brain disorders. The firm's products and solutions include radiotherapy, stereotactic radiosurgery, oncology in...